Simmonds MJ,Gough SC. Unravelling the genetic complexity of autoimmune thyroid disease:HLA,CTLA-4 and beyond[J]. Clin Exp Immunol,2004,136(1):1-10.
[2]
Einarsdottiv E,Soderstrom I,Lofgren Burstrom A, et al. The CTLA-4 region as a general autoimmunity factor:an external pedigree provide evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves'disease [J]. Eur J Hum Genet,2003,11(1):81-84.
Eagar TN, Karandikar NJ,Bluestone JA, et al. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance[J]. Eur J Immunol, 2002,32(4):972-981.
[5]
Ligers A, Teleshova N, Masterman T, et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms[J]. Genes Immun, 2001, 2(3):145-152.
[6]
Wang XB, Zhao X, Giscombe R, et al. A CTLA-4 gene polymorphism at position 318 in the promoter region affects the expression of protein[J]. Genes Immun,2002,3(4):233-234.
[7]
Yanagawa T,Hidaka Y,Guimaraes V, et al.CTLA-4 gene polymorphism associated with Graves'disease in a Caucasian population [J].Clin Endocrinol Metab,1995,80(1):41-45.
[8]
Antonio P, Gabriele G, Andrea G, et al. CT 60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte associated antigen-4 gene region is associated with Graves'Disease in an Italian population[J]. Thyroid, 2005,15(3):232-238.
[9]
Tomoyose T, Komiya I, Takara M, et al. Cytotoxic T lymphocyte antigen 4 gene polymorphisms and human T cell lymphotrophic virus1 infection: their associations with Hashimoto's thyroiditis in Japanese patients[J]. Thyroid, 2002,12(8):673-677.
[10]
Park YJ, Chung HK, Park DJ, et al. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans[J]. Thyroid, 2000,10(6): 453-459.
Donner H, Rm H, Walfish PG, et al. CTLA-4 Alanine-17 confers genetic susceptibility to Graves'disease and to type I diabetes mellitus[J]. J Clin Endocri Metab,1997,82(1):143-146.
